Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny plastics found in NICU Babies' blood – is IV nutrition to blame?

NCT ID NCT07326761

Knowledge-focused Sponsor: Huiyi Li Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether microplastics from plastic IV tubing get into the blood of premature babies in the NICU. Researchers compared 12 newborns who received IV nutrition for different lengths of time with those who did not. They used special equipment to count plastic particles in blood samples. The goal is to understand potential risks and guide safer medical practices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If confirmed, this could help make medical plastics safer for vulnerable newborns.
What could go wrong
This is a very small, early observational study with only 12 babies. It cannot prove cause and effect, and results may not apply to other hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jan 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 hour to 2 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Newborns hospitalized in neonatal intensive care unit of Guangdong Second People's Hospital in 2025. * The gestational age of birth is ≥ 28 weeks. * Intravenous nutrition time is 1-56 days. * The mother has no serious basic diseases (such as heart disease, chronic kidney disease, mental illness, hypertension, diabetes, etc.). Exclusion criteria: * There are serious congenital malformations or chromosomal abnormalities. Combined with other serious diseases that may affect the metabolism or distribution of microplastics (such as congenital metabolic abnormality, liver or renal insufficiency). * Parents or legal guardians withdraw informed consent. * Death or automatic discharge within 72 hours after birth.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Microplastics exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hyperphagia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Microplastics exposure

Contacts and locations

Locations

  • The Second People's Hospital of Guangdong Province affiliated to Jinan University

    Guangzhou, Guangdong, 510317, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.